ATED Therapeutics Named Finalist for the 2026 Asper PrizeJerusalem, Israel — May 20, 2026ATED Therapeutics announced today that it has been selected as a finalist for the 2026 Asper Prize, the Hebrew University of Jerusalem’s flagship award recognizing breakthrough innovation and global impact. This distinction places ATED Therapeutics among a select group of ventures chosen Continue Reading »
Read MoreThe new test can be used to identify pre-symptomatic patients with Parkinson’s and can monitor progression of the disease.
Read MoreThe new test can be used to identify pre-symptomatic patients with Parkinson’s disease and can measure progression of the disease.
Read MoreEarlier diagnosis of the degenerative disease raises hopes of more effective treatments
Read MoreTEL AVIV, Israel & GREENWICH, Conn. – (BUSINESS WIRE) – The winners and finalists of Fast Company’s 2024 World Changing Ideas Awards were announced today, highlighting fresh sustainability initiatives, cutting-edge AI developments, ambitious pursuits of social equity, and other creative projects that are helping mold the world. ATED Therapeutics, Ltd. was named a Finalist in Continue Reading »
Read More